COVID and post COVID

An independent study which indicates that Covishield produces significantly higher anti-spike antibodies after 2 doses compared to Covaxin based on a study of 515 healthcare workers in India. ...

Delta variant:B.1.617.2- 50%-70%⬆️transmissible l, 2.5x⬆️risk hospitalisation,⬆️in children,; vaccine escape ⬆️; 1 Vax Dose 34% protection, 2 Vax Doses 66% protection

This is regarding the 2nd wave. We have to judiciously mix these 2 Responses to come out unscathed and successful. Flight from the Enemy here is to avoid physically going where ever the...

Ventilator is used to support the lungs while ECMO completely bypasses it. Used when there is extensive damage to both lungs. To keep the patient alive till lung replacement. ECMO is basically arti...

Govt is considering giving them legal indemnity.

Don't take covid seriously. It kills the rich in high-tech countries, and hardly the poor. (Mortality share of rich countries is 78.6% and poor countries 0.2%, and remaining in between). This sho...

Over 11700 mucormycosis cases there now. Just to treat these cases we need 29 lakh plus vials of amphotericin. Cost per patient is Rs 5 lakh to 15 lakh just for amphotericin H...

Per research in the UK astrazeneca or covishield is only 60% effective post 2 doses against b.1.617.2

Covishield and Covaxine were released for Vacination with a gap of a few weeks. Bothe the vaccines were advised to be taken in 2 doses at a gap of 4 weeks. Then suddenly the expansion of vaccinatio...

Covaxin is not in the Emergency Use Listing of WHO. Those who used covaxin for vaccination in India will not be able to travel to America and Europe atleast for now. Those with Covishield can. Howe...